Exhibit 1

 

Joint Filing Statement

 

Statement Pursuant to Rule 13d-1(k)(1)

 

The undersigned hereby consent and agree to file a joint statement on Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock, $0.001 Par Value, of Intersect ENT, Inc., beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent and agree to file this Statement pursuant to Rule 13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule 13G.

 

Dated:June 9, 2020 Ayrton Capital LLC
     
  By: /s/ Waqas Khatri
  Name: Waqas Khatri
  Title: Managing Member
     
  Alto Opportunity Master Fund SPC – Segregated Master Portfolio B
     
  By: /s/ Waqas Khatri
  Name: Waqas Khatri
  Title: Managing Member
     
  Ayrton Capital LLC
   
  By: Waqas Khatri
     
     
  By: /s/ Waqas Khatri
  Name: Waqas Khatri
  Title: Managing Member